Blog Archive
-
▼
2007
(88)
-
▼
August
(15)
- Needle-Free Drug Delivery Technology for Diabetes ...
- BodyTel Scientific to Exhibit the GlucoTel System ...
- Pfizer and Bristol-Myers Squibb Worldwide Collabor...
- Teijin and Chugai, agreement to co-develop Ipsen's...
- Cannasat Therapeutics, Commence Phase 1 Study of C...
- AtheroGenics , Phase III clinical trial of AGI-106...
- Blood Glucose Meter, Medtronic and LifeScan Annou...
- Sirtris Pharmaceuticals, SRT501 product candidate ...
- Blood Glucose Meter, Medtronic and Bayer Diabetes ...
- Novo Nordisk, Liraglutide improves glucose control
- Diabetic Neuropathic Pain, UCB's subsidiary SCHWAR...
- Oramed oral insulin gel capsule
- CombinatoRx CRx-401 for Type 2 Diabetes
- Avigen, Neuropathic Pain : Clinical Development fo...
- a news diabetes blog
-
▼
August
(15)
Thursday, August 30, 2007
BodyTel Scientific to Exhibit the GlucoTel System blood glucose monitoring with Bluetooth
Aug. 29, 2007 (PRIME NEWSWIRE) -- BodyTel Scientific, Inc. (OTCBB:BDYT) will be attending the first Primary Healthcare Exhibition and Congress at the Abu Dhabi National Exhibition Centre in the United Arab Emirates September 2-4. At the event, BodyTel Scientific will be showcasing their flagship telemedicine-based diabetes self-management solution, GlucoTel at booth 4D10.(...) The meter is part of the GlucoTel system, a complete telemedical diabetes self-management system supporting patients and doctors in the treatment of diabetes... read the BodyTel's Press Release. -